C4 Therapeutics Statistics
NASDAQ: CCCCHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
2.82-0.06 (-2.08%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
C4 Therapeutics by the numbers
C4 Therapeutics has a market capitalization of $346.9 million based on 123.03M shares outstanding. With trailing EPS of $-0.91, C4 Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 21.8% below its 50-day average and 9.7% below its 200-day average.
Average daily trading volume is 2.45M shares, or about $6.9 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CCCC valuation vs. peer median
| Metric | CCCC | Peer median | Difference |
|---|---|---|---|
| Market cap | $346.93M | $342.05M | +1% |
| Avg. volume | 2.45M | 1.15M | +113% |
Peer median across 8 companies: FENC, ARTV, AGEN, OCGN, CABA, SCTX, KYTX, ZURA.
Valuation
- Market cap
- $346.93M
- EPS (TTM)
- $-0.91
- Shares outstanding
- 123.03M
Price and trading
- Previous close
- 2.88
- Open
- 2.85
- Day range
- 2.82 – 2.95
- 52-week range
- 1.69 – 5.17
- 52-week change
- +24.78%
- Beta
- —
- Volume
- 2.27M
- Average volume
- 2.45M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 346.93M
- Forward Pe
- -2.83
- Eps
- -0.91
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 5.17
- Week52 Low
- 1.69
- Avg Volume
- 2.45M
- Shares Outstanding
- 123.03M
- Ma50
- 3.61
- Ma200
- 3.12
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -45.45%
- Pct From52w Low
- 66.86%